Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 10
2006 4
2007 2
2008 6
2009 10
2010 7
2011 10
2012 13
2013 14
2014 14
2015 12
2016 11
2017 9
2018 10
2019 11
2020 10
2021 10
2022 9
2023 6
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Recurrence in Breast Noninvasive Neoplasia: A 10-Year Follow-Up of TAM-01 Study.
Lazzeroni M, Puntoni M, Guerrieri-Gonzaga A, Serrano D, Boni L, Buttiron Webber T, Fava M, Briata IM, Giordano L, Digennaro M, Cortesi L, Falcini F, Serra P, Avino F, Millo F, Cagossi K, Gallerani E, De Simone A, Cariello A, Aprile G, Renne M, Bonanni B, DeCensi A. Lazzeroni M, et al. Among authors: puntoni m. J Clin Oncol. 2023 Jun 10;41(17):3116-3121. doi: 10.1200/JCO.22.02900. Epub 2023 Mar 14. J Clin Oncol. 2023. PMID: 36917758 Clinical Trial.
Il servizio sanitario ha bisogno di personale competente in ricerca?
Caminiti C, Maglietta G, Puntoni M, Diodati F, Marcomini B, Lazzarelli S, Rossolini V. Caminiti C, et al. Among authors: puntoni m. Recenti Prog Med. 2023 Sep;114(9):525-526. doi: 10.1701/4088.40796. Recenti Prog Med. 2023. PMID: 37530003 Italian. No abstract available.
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia.
DeCensi A, Puntoni M, Guerrieri-Gonzaga A, Caviglia S, Avino F, Cortesi L, Taverniti C, Pacquola MG, Falcini F, Gulisano M, Digennaro M, Cariello A, Cagossi K, Pinotti G, Lazzeroni M, Serrano D, Branchi D, Campora S, Petrera M, Buttiron Webber T, Boni L, Bonanni B. DeCensi A, et al. Among authors: puntoni m. J Clin Oncol. 2019 Jul 1;37(19):1629-1637. doi: 10.1200/JCO.18.01779. Epub 2019 Apr 11. J Clin Oncol. 2019. PMID: 30973790 Free PMC article. Clinical Trial.
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET.
Gennari A, Brain E, De Censi A, Nanni O, Wuerstlein R, Frassoldati A, Cortes J, Rossi V, Palleschi M, Alberini JL, Matteucci F, Piccardo A, Sacchetti G, Ilhan H, D'Avanzo F, Ruffilli B, Nardin S, Monti M, Puntoni M, Fontana V, Boni L, Harbeck N; ET-FES Collaborative Group. Gennari A, et al. Among authors: puntoni m. Ann Oncol. 2024 Jun;35(6):549-558. doi: 10.1016/j.annonc.2024.02.007. Epub 2024 Feb 28. Ann Oncol. 2024. PMID: 38423389 Clinical Trial.
True prevalence of long COVID in children: a narrative review.
Esposito S, Deolmi M, Ramundo G, Puntoni M, Caminiti C, Principi N. Esposito S, et al. Among authors: puntoni m. Front Microbiol. 2023 Sep 14;14:1225952. doi: 10.3389/fmicb.2023.1225952. eCollection 2023. Front Microbiol. 2023. PMID: 37789860 Free PMC article. Review.
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
Leonetti A, Perrone F, Puntoni M, Maglietta G, Bordi P, Bria E, Vita E, Gelsomino F, De Giglio A, Gelibter A, Siringo M, Mazzoni F, Caliman E, Genova C, Bertolini F, Guaitoli G, Passiglia F, Delcuratolo MD, Montrone M, Cerea G, Pasello G, Roca E, Belluomini L, Cecere FL, Guida A, Manzo A, Adamo V, Rastelli F, Bulotta A, Citarella F, Toschi L, Zoratto F, Cortinovis DL, Berardi R, Follador A, Carta A, Camerini A, Salerno F, Silva RR, Baldini E, Cortellini A, Brighenti M, Santoni M, Malorgio F, Caminiti C, Tiseo M. Leonetti A, et al. Among authors: puntoni m. Eur J Cancer. 2024 May;202:114006. doi: 10.1016/j.ejca.2024.114006. Epub 2024 Mar 11. Eur J Cancer. 2024. PMID: 38489861
Repurposing old drugs to chemoprevention: the case of metformin.
Heckman-Stoddard BM, Gandini S, Puntoni M, Dunn BK, DeCensi A, Szabo E. Heckman-Stoddard BM, et al. Among authors: puntoni m. Semin Oncol. 2016 Feb;43(1):123-133. doi: 10.1053/j.seminoncol.2015.09.009. Epub 2015 Sep 8. Semin Oncol. 2016. PMID: 26970131 Free PMC article. Review.
64CuCl2 PET/CT in Prostate Cancer Relapse.
Piccardo A, Paparo F, Puntoni M, Righi S, Bottoni G, Bacigalupo L, Zanardi S, DeCensi A, Ferrarazzo G, Gambaro M, Ruggieri FG, Campodonico F, Tomasello L, Timossi L, Sola S, Lopci E, Cabria M. Piccardo A, et al. Among authors: puntoni m. J Nucl Med. 2018 Mar;59(3):444-451. doi: 10.2967/jnumed.117.195628. Epub 2017 Sep 8. J Nucl Med. 2018. PMID: 28887398 Free article. Clinical Trial.
Inflammation and cancer prevention.
Puntoni M, Marra D, Zanardi S, Decensi A. Puntoni M, et al. Ann Oncol. 2008 Sep;19 Suppl 7:vii225-9. doi: 10.1093/annonc/mdn442. Ann Oncol. 2008. PMID: 18790956 Free article. Review. No abstract available.
160 results